390 related articles for article (PubMed ID: 17403708)
41. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
[TBL] [Abstract][Full Text] [Related]
42. Antibiotic resistance surveillance over a 4-year period (2000-2003) in Turkey: results of the MYSTIC Program.
Korten V; Ulusoy S; Zarakolu P; Mete B;
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):453-7. PubMed ID: 17888609
[TBL] [Abstract][Full Text] [Related]
43. A guide to antibiotic resistance in bacterial skin infections.
Perera G; Hay R
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):531-45. PubMed ID: 16164705
[TBL] [Abstract][Full Text] [Related]
44. Emergence and spread of antibiotic-resistant Gram-positive bacterial pathogens.
Witte W; Cuny C; Klare I; Nübel U; Strommenger B; Werner G
Int J Med Microbiol; 2008 Jul; 298(5-6):365-77. PubMed ID: 18325835
[TBL] [Abstract][Full Text] [Related]
45. Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing.
Hecht DW
Anaerobe; 2006 Jun; 12(3):115-21. PubMed ID: 16765857
[No Abstract] [Full Text] [Related]
46. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
Sparo MD; Jones DG; Sánchez Bruni SF
Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
[TBL] [Abstract][Full Text] [Related]
47. The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents.
Murphy ST; Case HL; Ellsworth E; Hagen S; Huband M; Joannides T; Limberakis C; Marotti KR; Ottolini AM; Rauckhorst M; Starr J; Stier M; Taylor C; Zhu T; Blaser A; Denny WA; Lu GL; Smaill JB; Rivault F
Bioorg Med Chem Lett; 2007 Apr; 17(8):2150-5. PubMed ID: 17303420
[TBL] [Abstract][Full Text] [Related]
48. Antimicrobial peptides: promising alternatives to conventional antibiotics.
Baltzer SA; Brown MH
J Mol Microbiol Biotechnol; 2011; 20(4):228-35. PubMed ID: 21894027
[TBL] [Abstract][Full Text] [Related]
49. [Resistance of causative agents of uncomplicated urinary tract infections in Russia].
Rafal'skiĭ VV; Strachunskiĭ LS; Babkin PA; Valenskaia VS; Gabbasova LA; Dmitrieva OB; Emel'ianova IV; Krupin VN; Malev IV; Petrov SB; Rokhlikov IM; Furletova NM; Khaĭrullov AS
Urologiia; 2006; (5):34-7. PubMed ID: 17444150
[TBL] [Abstract][Full Text] [Related]
50. Impact of antibiotic resistance in gram-negative bacilli on empirical and definitive antibiotic therapy.
Paterson DL
Clin Infect Dis; 2008 Sep; 47 Suppl 1():S14-20. PubMed ID: 18713045
[TBL] [Abstract][Full Text] [Related]
51. [Guides for rational use of B-lactam antibiotics:resistance mechanism and clinical interpretation].
Arias CA; Panesso D; Zúñiga M
Biomedica; 2003 Jun; 23(2):134-40. PubMed ID: 12872552
[TBL] [Abstract][Full Text] [Related]
52. Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.
Pea F; Viale P
Expert Rev Anti Infect Ther; 2007 Apr; 5(2):255-70. PubMed ID: 17402840
[TBL] [Abstract][Full Text] [Related]
53. [Analysis of predominant bacteria of burn infection and their resistance to antibiotics in recent years].
Li M; Zhang GA; Liu Y
Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):91-3. PubMed ID: 17649879
[TBL] [Abstract][Full Text] [Related]
54. [Microbial flora and sensitivity to antibiotics in surgical abdominal infection].
Potapov AF
Anesteziol Reanimatol; 2004; (2):52-4. PubMed ID: 15206280
[TBL] [Abstract][Full Text] [Related]
55. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
Seral C; Carryn S; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2003 May; 51(5):1167-73. PubMed ID: 12697643
[TBL] [Abstract][Full Text] [Related]
56. Inhibitors of efflux pumps in Gram-negative bacteria.
Pagès JM; Masi M; Barbe J
Trends Mol Med; 2005 Aug; 11(8):382-9. PubMed ID: 15996519
[TBL] [Abstract][Full Text] [Related]
57. Microorganisms Profile and Antibiotics Sensitivity Patterns in the Only Medical Intensive Care Unit in Bosnia and Herzegovina.
Kovacevic P; Zlojutro B; Kovacevic T; Baric G; Dragic S; Momcicevic D
Microb Drug Resist; 2019 Oct; 25(8):1176-1181. PubMed ID: 31120362
[TBL] [Abstract][Full Text] [Related]
58. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006.
Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ;
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913
[TBL] [Abstract][Full Text] [Related]
59. N-acetylcysteine inhibits growth, adhesion and biofilm formation of Gram-positive skin pathogens.
Eroshenko D; Polyudova T; Korobov V
Microb Pathog; 2017 Apr; 105():145-152. PubMed ID: 28237766
[TBL] [Abstract][Full Text] [Related]
60. Multidrug-resistant Gram-negative bacteria in postoperative infections.
Singh AV; Mishra B; Thakur A
J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
